Genpact Limited (G) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 1.84%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 1.84% | Share-based compensation / revenue. Period ending 2026-06-30. $96.41M ÷ $5.25B × 100 ≈ 1.84% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 5.25B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 96.41M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 778.63M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $5.25B | $96.41M | $778.63M | (m) | (m) | 1.84% | (m) | (m) |
| 2026-03-31 | (m) | $5.16B | $91.85M | $765.09M | (m) | (m) | 1.78% | (m) | (m) |
| 2025-12-31 | (m) | $5.08B | $89.62M | $750.21M | (m) | (m) | 1.76% | (m) | (m) |
| 2025-09-30 | (m) | $5.01B | $83.16M | $744.92M | (m) | (m) | 1.66% | (m) | (m) |
| 2025-06-30 | (m) | $4.93B | $80.67M | $734.93M | (m) | (m) | 1.64% | (m) | (m) |
| 2025-03-31 | (m) | $4.85B | $77.24M | $725.78M | (m) | (m) | 1.59% | (m) | (m) |
| 2024-12-31 | (m) | $4.77B | $66.38M | $702.06M | (m) | (m) | 1.39% | (m) | (m) |
| 2024-09-30 | (m) | $4.66B | $72.00M | $674.62M | (m) | (m) | 1.54% | (m) | (m) |
| 2024-06-30 | (m) | $4.59B | $74.59M | $658.66M | (m) | (m) | 1.63% | (m) | (m) |
| 2024-03-31 | (m) | $4.52B | $78.05M | $645.73M | (m) | (m) | 1.73% | (m) | (m) |
| 2023-12-31 | (m) | $4.48B | $88.58M | $630.86M | (m) | (m) | 1.98% | (m) | (m) |
| 2023-09-30 | (m) | $4.43B | $86.33M | $595.88M | (m) | (m) | 1.95% | (m) | (m) |
| 2023-06-30 | (m) | $4.41B | $83.22M | $561.02M | (m) | (m) | 1.89% | (m) | (m) |
| 2023-03-31 | (m) | $4.39B | $81.83M | $513.39M | (m) | (m) | 1.86% | (m) | (m) |
| 2022-12-31 | (m) | $4.37B | $77.37M | $502.15M | (m) | (m) | 1.77% | (m) | (m) |
| 2022-09-30 | (m) | $4.34B | $78.26M | $486.32M | (m) | (m) | 1.80% | (m) | (m) |
| 2022-06-30 | (m) | $4.25B | $80.54M | $487.77M | (m) | (m) | 1.90% | (m) | (m) |
| 2022-03-31 | (m) | $4.14B | $79.79M | $514.99M | (m) | (m) | 1.93% | (m) | (m) |
| 2021-12-31 | (m) | $4.02B | $81.97M | $509.00M | (m) | (m) | 2.04% | (m) | (m) |
| 2021-09-30 | (m) | $3.90B | $76.79M | $510.13M | (m) | (m) | 1.97% | (m) | (m) |
| 2021-06-30 | (m) | $3.82B | $74.80M | $502.48M | (m) | (m) | 1.96% | (m) | (m) |
| 2021-03-31 | (m) | $3.73B | $73.95M | $455.94M | (m) | (m) | 1.98% | (m) | (m) |
| 2020-12-31 | (m) | $3.71B | $74.01M | $438.72M | (m) | (m) | 2.00% | (m) | (m) |
| 2020-09-30 | (m) | $3.70B | $78.40M | $445.18M | (m) | (m) | 2.12% | (m) | (m) |
| 2020-06-30 | (m) | $3.65B | $80.23M | $434.12M | (m) | (m) | 2.20% | (m) | (m) |
| 2020-03-31 | (m) | $3.63B | $82.91M | $449.96M | (m) | (m) | 2.28% | (m) | (m) |
| 2019-12-31 | (m) | $3.52B | $83.89M | $429.38M | (m) | (m) | 2.38% | (m) | (m) |
| 2019-09-30 | (m) | $3.42B | $78.15M | $420.70M | (m) | (m) | 2.29% | (m) | (m) |
| 2019-06-30 | (m) | $3.27B | $70.26M | $401.14M | (m) | (m) | 2.15% | (m) | (m) |
| 2019-03-31 | (m) | $3.12B | $59.67M | $374.46M | (m) | (m) | 1.91% | (m) | (m) |
| 2018-12-31 | (m) | $3.00B | $49.00M | $348.15M | (m) | (m) | 1.63% | (m) | (m) |
| 2018-09-30 | (m) | (m) | $45.44M | $307.96M | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | $42.06M | $311.86M | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | $38.49M | $313.29M | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | (m) | $35.69M | $328.63M | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | (m) | $29.17M | $354.67M | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | $23.95M | $344.34M | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | $24.76M | $344.25M | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | (m) | $25.11M | $340.78M | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | (m) | (m) | $25.81M | $326.13M | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | $27.18M | $326.35M | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | (m) | $25.65M | $335.76M | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | (m) | $24.98M | $334.19M | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | (m) | $2.42B | $25.42M | $321.61M | (m) | (m) | 1.05% | (m) | (m) |
| 2015-06-30 | (m) | $2.39B | $27.50M | $307.14M | (m) | (m) | 1.15% | (m) | (m) |
| 2015-03-31 | (m) | $2.34B | $27.75M | $290.83M | (m) | (m) | 1.19% | (m) | (m) |
| 2014-12-31 | (m) | $2.28B | $28.07M | $294.03M | (m) | (m) | 1.23% | (m) | (m) |
| 2014-09-30 | (m) | $2.24B | $29.35M | $294.80M | (m) | (m) | 1.31% | (m) | (m) |
| 2014-06-30 | (m) | $2.18B | $26.39M | $307.89M | (m) | (m) | 1.21% | (m) | (m) |
| 2014-03-31 | (m) | $2.16B | $29.58M | $312.82M | (m) | (m) | 1.37% | (m) | (m) |
| 2013-12-31 | (m) | $2.13B | $31.13M | $309.53M | (m) | (m) | 1.46% | (m) | (m) |
| 2013-09-30 | (m) | $2.08B | $31.23M | $308.69M | (m) | (m) | 1.50% | (m) | (m) |
| 2013-06-30 | (m) | $2.04B | $31.53M | $292.68M | (m) | (m) | 1.55% | (m) | (m) |
| 2013-03-31 | (m) | $1.97B | $31.41M | $277.86M | (m) | (m) | 1.59% | (m) | (m) |
| 2012-12-31 | (m) | $1.90B | $32.15M | $264.35M | (m) | (m) | 1.69% | (m) | (m) |
| 2012-09-30 | (m) | $1.84B | $32.91M | $255.48M | (m) | (m) | 1.79% | (m) | (m) |
| 2012-06-30 | (m) | $1.78B | $36.45M | $242.27M | (m) | (m) | 2.05% | (m) | (m) |
| 2012-03-31 | (m) | $1.71B | $31.96M | $230.17M | (m) | (m) | 1.87% | (m) | (m) |
| 2011-12-31 | (m) | $1.60B | $27.77M | $216.24M | (m) | (m) | 1.73% | (m) | (m) |
| 2011-09-30 | (m) | $1.50B | $20.26M | $214.20M | (m) | (m) | 1.35% | (m) | (m) |
| 2011-06-30 | (m) | $1.39B | $15.79M | $199.88M | (m) | (m) | 1.13% | (m) | (m) |
| 2011-03-31 | (m) | $1.30B | $16.09M | $187.11M | (m) | (m) | 1.24% | (m) | (m) |
| 2010-12-31 | (m) | $1.26B | $17.51M | $177.86M | (m) | (m) | 1.39% | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | $1.12B | $19.29M | $162.18M | (m) | (m) | 1.72% | (m) | (m) |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | $1.04B | $16.94M | $133.71M | (m) | (m) | 1.63% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FTI CONSULTING, INC (FCN) | United States | $3.602B | 16.33 |
| EXPONENT INC (EXPO) | United States | $3.065B | 26.46 |
| Huron Consulting Group Inc. (HURN) | United States | $2.557B | 20.80 |
| Booz Allen Hamilton Holding Corp (BAH) | United States | $8.878B | 9.38 |
| Astrana Health, Inc. (ASTH) | United States | $1.921B | 63.77 |
| ICF International, Inc. (ICFI) | United States | $1.490B | 14.74 |
| Bowman Consulting Group Ltd. (BWMN) | United States | $0.738B | 68.09 |
| Onterris, Inc. (ONT) | United States | $0.590B | -63.69 |
| Public Policy Holding Company, Inc. (PPHC) | United States | $0.347B | |
| Aeries Technology, Inc. (AERT) | Cayman Islands | $0.336B | -0.00 |